These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 37520534)

  • 21. Single-cell atlas reveals a distinct immune profile fostered by T cell-B cell crosstalk in triple negative breast cancer.
    Ding S; Qiao N; Zhu Q; Tong Y; Wang S; Chen X; Tian Q; Xiao Y; Shen K
    Cancer Commun (Lond); 2023 Jun; 43(6):661-684. PubMed ID: 37158690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of Prognosis and Immunotherapy Response with a Novel Natural Killer Cell Marker Genes Signature in Osteosarcoma.
    Li Q; Huang X; Zhao Y
    Cancer Biother Radiopharm; 2023 Oct; ():. PubMed ID: 37889617
    [No Abstract]   [Full Text] [Related]  

  • 23. CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.
    Cheng T; Wu Y; Liu Z; Yu Y; Sun S; Guo M; Sun B; Huang C
    Front Immunol; 2022; 13():970950. PubMed ID: 36052076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated analysis of single-cell and bulk RNA-sequencing reveals a novel signature based on NK cell marker genes to predict prognosis and immunotherapy response in gastric cancer.
    Sun JR; Kong CF; Ye YX; Wang Q; Qu XK; Jia LQ; Wu S
    Sci Rep; 2024 Apr; 14(1):7648. PubMed ID: 38561388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an ubiquitin-proteasome system signature for predicting prognosis and providing therapeutic guidance for patients with triple-negative breast cancer.
    Chen X; Ren C; Zhou Z; Chen J; Fan X; Li X; Chen J; Zhu J
    J Gene Med; 2024 Jan; 26(1):e3584. PubMed ID: 37605934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prognostic marker KRT81 is involved in suppressing CD8 + T cells and predicts immunotherapy response for triple-negative breast cancer.
    Yan Z; Zhong Z; Shi C; Feng M; Feng X; Liu T
    Cancer Biol Ther; 2024 Dec; 25(1):2355705. PubMed ID: 38778753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of ICAM1 in tumor immunity and prognosis of triple-negative breast cancer.
    Zhou Q; Xu J; Xu Y; Sun S; Chen J
    Front Immunol; 2023; 14():1176647. PubMed ID: 37671167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy.
    Zhou Y; Che Y; Fu Z; Zhang H; Wu H
    Front Public Health; 2022; 10():902378. PubMed ID: 35875026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
    Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
    Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel natural killer-related signature to effectively predict prognosis in hepatocellular carcinoma.
    Xi D; Wang J; Yang Y; Ji F; Li C; Yan X
    BMC Med Genomics; 2023 Sep; 16(1):211. PubMed ID: 37674210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on NK cell marker genes to predict prognosis and immunotherapy response in hepatocellular carcinoma.
    Yang D; Zhao F; Su Y; Zhou Y; Shen J; Yu B; Zhao K; Ding Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10609-10621. PubMed ID: 37296316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 34. Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature.
    Qin Y; Deng J; Zhang L; Yuan J; Yang H; Li Q
    Aging (Albany NY); 2021 Feb; 13(4):5485-5505. PubMed ID: 33536349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels T cell-related prognostic risk model and tumor immune microenvironment modulation in triple-negative breast cancer.
    Guo S; Liu X; Zhang J; Huang Z; Ye P; Shi J; Stalin A; Wu C; Lu S; Zhang F; Gao Y; Jin Z; Tao X; Huang J; Zhai Y; Shi R; Guo F; Zhou W; Wu J
    Comput Biol Med; 2023 Jul; 161():107066. PubMed ID: 37263064
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of DDIT4 as a potential prognostic marker associated with chemotherapeutic and immunotherapeutic response in triple-negative breast cancer.
    Chen X; Li Z; Liang M; Zhang Z; Zhu D; Lin B; Zhou R; Lu Y
    World J Surg Oncol; 2023 Jun; 21(1):194. PubMed ID: 37391802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Model for predicting immunotherapy based on M2 macrophage infiltration in TNBC.
    Wu H; Feng J; Zhong W; Zouxu X; Xiong Z; Huang W; Zhang C; Wang X; Yi J
    Front Immunol; 2023; 14():1151800. PubMed ID: 36999020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a Hypoxia-Related Molecular Classification and Hypoxic Tumor Microenvironment Signature for Predicting the Prognosis of Patients with Triple-Negative Breast Cancer.
    Sun X; Luo H; Han C; Zhang Y; Yan C
    Front Oncol; 2021; 11():700062. PubMed ID: 34490098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting the Prognosis and Immunotherapeutic Response of Triple-Negative Breast Cancer by Constructing a Prognostic Model Based on CD8+ T Cell-Related Immune Genes.
    Li NN; Qiu XT; Xue JS; Yi LM; Chen ML; Huang ZJ
    Biomed Environ Sci; 2024 Jun; 37(6):581-593. PubMed ID: 38988109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis.
    Ma J; Chen C; Liu S; Ji J; Wu D; Huang P; Wei D; Fan Z; Ren L
    Cancer Gene Ther; 2022 Nov; 29(11):1578-1589. PubMed ID: 35474355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.